drugset / Trial / NCT03780166
A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris
SequentialOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability of parsaclisib in participants with mild to moderate pemphigus vulgaris.
Timeline
- Start
- 2019-03
- Primary completion
- 2020-11
- Completion
- 2020-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Parsaclisib | Small molecule | — | Oral |